{"date":"2026-04-24","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4131-2026-04-24-2250-1gl2k65","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-04-24","time":"22:50:11","subject":"代母公司廣泰金屬工業(股)公司公告董事會決議召開民國115年股東常會","clause":"第17款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-04-24 22:50，「代母公司廣泰金屬工業(股)公司公告董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-04-24-2048-i043eu","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"20:48:47","subject":"公告本公司董事會通過營業地址變更案","clause":"第44款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-04-24 20:48，「公告本公司董事會通過營業地址變更案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-04-24-2026-b4o5wd","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"20:26:53","subject":"公告本公司董事會決議限制員工權利新股收回減資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-04-24 20:26，「公告本公司董事會決議限制員工權利新股收回減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-04-24-1841-1u7pahz","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"18:41:58","subject":"董事會決議不分派股利","clause":"第31款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-04-24 18:41，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-04-24-1812-1bgitwp","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-04-24","time":"18:12:32","subject":"民國115年第一季財務報告董事會預計召開日期為民國115年05月04日","clause":"第31款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-04-24 18:12，「民國115年第一季財務報告董事會預計召開日期為民國115年05月04日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-04-24-1739-sv9y6q","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"17:39:06","subject":"公告本公司董事解任事宜","clause":"第6款","fact_date":"2026-04-25","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-04-24 17:39，「公告本公司董事解任事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-04-24-1723-1r1w2m4","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"17:23:39","subject":"本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-04-24 17:23，「本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-04-24-1711-t3bsot","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-04-24","time":"17:11:41","subject":"公告本公司財務主管、會計主管、公司治理主管及代理發言人異動","clause":"第8款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-04-24 17:11，「公告本公司財務主管、會計主管、公司治理主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-04-24-1710-1fry2sp","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-24","time":"17:10:49","subject":"公告本公司股票初次上市前現金增資員工認購股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-24 17:10，「公告本公司股票初次上市前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-04-24-1702-1bkm0mx","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"17:02:57","subject":"公告本公司代理發言人異動","clause":"第11款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-04-24 17:02，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-04-24-1702-x9qbbu","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"17:02:24","subject":"公告本公司董事會通過技術長任命案","clause":"第11款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-04-24 17:02，「公告本公司董事會通過技術長任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-04-24-1701-1icev2h","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"17:01:48","subject":"公告本公司稽核主管異動案","clause":"第11款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-04-24 17:01，「公告本公司稽核主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-04-24-1700-bsfxdj","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"17:00:58","subject":"公告本公司會計主管異動案","clause":"第11款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-04-24 17:00，「公告本公司會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-04-24-1650-1g6i233","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-04-24","time":"16:50:44","subject":"公告本公司董事長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-04-24 16:50，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-04-24-1612-f5rbon","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"16:12:47","subject":"補充公告本公司以自地委建方式興建竹南廠房(補充114年5月16日公告)","clause":"第17款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-04-24 16:12，「補充公告本公司以自地委建方式興建竹南廠房(補充114年5月16日公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-04-24-1505-15w1hx6","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"15:05:14","subject":"公告本公司董事會決議召開115年股東常會(新增議案)","clause":"第32款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-04-24 15:05，「公告本公司董事會決議召開115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-04-24-1504-cthdnn","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-04-24","time":"15:04:44","subject":"公告本公司董事會決議通過辦理私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-04-24 15:04，「公告本公司董事會決議通過辦理私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2026-04-24-1437-1svedv6","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2026-04-24","time":"14:37:05","subject":"公告本公司115年第一季合併財務報告董事會預計召開日期為115年05月04日","clause":"第31款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2026-04-24 14:37，「公告本公司115年第一季合併財務報告董事會預計召開日期為115年05月04日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-04-24-1404-twdbzl","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-24","time":"14:04:53","subject":"代子公司天津紅日健達康醫藥科技有限公司與枕石生物醫藥科技（珠海）有限公司簽訂推廣許可協議公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-04-24 14:04，「代子公司天津紅日健達康醫藥科技有限公司與枕石生物醫藥科技（珠海）有限公司簽訂推廣許可協議公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}